- Offizieller Beitrag
das müsste ich mir nochmal in ruhe ansehen..gibt es dazu eine oder mehreren studien?
https://pubmed-ncbi-nlm-nih-gov.translate.goog/32875286/?_x_t…e&_x_tr_pto=nui
Antibody response is often a poor marker of prior coronavirus infection, particularly in mild infections, and is shorter-lived than virus-reactive T-cells; strong antibody response correlates with more severe clinical disease while T-cell response is correlated with less severe disease; and antibody-dependent enhancement of pathology and clinical severity has been described.
Veröffentlicht in Dez. 2020, wo die Geninjektionen begannen